Drs. Richard Greene and Gordon Thomas of NJIT collaborate with Dr. Robert Fechtner (center), director of the glaucoma division at UMDNJ-New Jersey Medical School. The team will develop devices to prevent blindness through the New Jersey Vision Technology Center.
NJIT biomedical researchers are collaborating with physicians as well as private companies to develop new medical devices to combat eye diseases through the New Jersey Vision Technology Center. Lead by Richard Greene, Becton-Dickinson professor of biomedical engineering, the center was established with a one-year seed grant from the New Jersey Commission on Science and Technology.
In addition to improving the diagnosis and management of diseases such as glaucoma and diabetes, the center aims to spur economic development in the state's biotechnology industry, by developing useful medical devices with promising commercial prospects. Current projects include a device to allow simplified eye pressure testing for glaucoma patients, and another to measure blood sugar. In each of the center's research projects, scientists and clinicians work closely with a New Jersey firm whose R&D staff help to turn prototypes into products.
The Vision Center is also funded by grants from the National Medical Technology Testbed (Department of the Army) the Gustavus and Louise Pfeiffer Research Foundation, of Denville, N.J., as well as by funds from Becton Dickinson, Inc, and Lucent Technologies. The center team includes Gordon Thomas, Avid Kamgar and Tara Alvarez at NJIT, and Dr. Robert Fechtner of UMDNJ-New Jersey Medical School.